Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms

abstract

  • Neoadjuvant chemotherapy can completely clear the axilla of microscopic disease before surgery, and occult metastases are found in only 10% of patients with a histologically negative axilla. The results of this study have implications for the potential use of sentinel lymph node biopsy as an alternative to axillary dissection in patients treated with neoadjuvant chemotherapy.

publication date

  • July 1999

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC1420847

Digital Object Identifier (DOI)

  • 10.1097/00000658-199907000-00011

PubMed ID

  • 10400039

Additional Document Info

start page

  • 72

end page

  • 8

volume

  • 230

number

  • 1